Medicine
Fosamprenavir 700 mg tablet
Fosamprenavir 700 mg tablet is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° C to 25° C (68° F to 77° F). Protect from moisture.
Key facts
- Active ingredient (INN)
- Fosamprenavir
- Brand
- Sold under the generic name
- Strength
- 700 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 30 tablets, 60 tablets and 1 more
- Manufacturers
- Sun Pharmaceutical IndustriesIndiaMylan Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° C to 25° C (68° F to 77° F). Protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AE07 Fosamprenavir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 September 2017
- Identifiers
- RxCUI 402109DailyMed set ID 5cd1eead-9fc1-426c-bee8-214ffa7d9dc1, 3a1424d8-844c-4e24-9ebd-b2c2b61b61a3NDC 63304-583, 0378-3520Application ANDA204024, ANDA204060
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, coated in 1 bottle | 63304-583-01 | Sun Pharmaceutical IndustriesIndia | 28 November 2019 |
| 30 tablet, coated in 1 bottle | 63304-583-30 | Sun Pharmaceutical IndustriesIndia | 28 November 2019 |
| 60 tablet, coated in 1 bottle | 63304-583-60 | Sun Pharmaceutical IndustriesIndia | 28 November 2019 |
| 60 tablet, film coated in 1 bottle, plastic | 0378-3520-91 | Mylan Pharmaceuticals | 18 September 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Fosamprenavir is a protease inhibitor indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection. It is available as tablets for oral use. MedsAcross supplies Fosamprenavir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FosamprenavirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Fosamprenavir Calcium prescribing information (Sun Pharmaceutical Industries) · U.S. National Library of Medicine, DailyMed
Need Fosamprenavir 700 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.